Protein,Protein_definition,Disease_category,Disease,Method,Nb_SNP,OR[95%CI],P_value
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter I Certain infectious and parasitic diseases,Candidiasis,Inverse variance weighted,8,1.00 [0.72-1.40],0.976924158385767
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,Inverse variance weighted,8,0.97 [0.89-1.05],0.437348062570738
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,Inverse variance weighted,8,1.00 [0.93-1.06],0.886202832193959
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter I Certain infectious and parasitic diseases,Mycoses,Inverse variance weighted,8,0.98 [0.83-1.16],0.859042316733249
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,Inverse variance weighted,8,1.02 [0.96-1.08],0.582110473622822
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,Inverse variance weighted,8,0.74 [0.34-1.60],0.447509945889647
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter I Certain infectious and parasitic diseases,Other septicaemia,Inverse variance weighted,8,0.99 [0.84-1.17],0.889889772092325
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter I Certain infectious and parasitic diseases,Other viral diseases,Inverse variance weighted,8,1.06 [0.92-1.22],0.418066192601098
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,Inverse variance weighted,8,0.40 [0.14-1.09],0.0720240586863593
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",Inverse variance weighted,8,0.95 [0.81-1.12],0.55859515173407
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,Inverse variance weighted,8,1.06 [0.91-1.22],0.463293891870198
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,Inverse variance weighted,8,0.98 [0.73-1.30],0.871408880861924
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",Inverse variance weighted,8,0.79 [0.55-1.15],0.219031661633903
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter X Diseases of the respiratory system,Early onset COPD,Inverse variance weighted,8,0.95 [0.77-1.16],0.602374478209878
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter X Diseases of the respiratory system,Later onset COPD,Inverse variance weighted,8,1.00 [0.85-1.19],0.992169348839171
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,Inverse variance weighted,8,0.85 [0.51-1.42],0.532645391932837
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,Inverse variance weighted,8,0.97 [0.80-1.18],0.791817080144738
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,Inverse variance weighted,8,1.00 [0.87-1.17],0.951450409510621
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,Inverse variance weighted,8,1.15 [0.56-2.40],0.701180265831678
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,Inverse variance weighted,8,1.17 [0.78-1.74],0.446693851534951
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,Inverse variance weighted,8,1.04 [0.85-1.27],0.722614894222389
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",Inverse variance weighted,8,1.05 [0.79-1.40],0.732892104252095
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",Inverse variance weighted,8,0.99 [0.81-1.20],0.916053555461099
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,Inverse variance weighted,8,1.32 [1.04-1.68],0.0224918995675888
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,Inverse variance weighted,8,0.90 [0.34-2.42],0.83692470329275
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,Inverse variance weighted,8,1.26 [0.94-1.68],0.117698950788288
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,Inverse variance weighted,8,0.88 [0.64-1.20],0.420021368260498
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,Inverse variance weighted,8,0.98 [0.73-1.32],0.907880574993213
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,Inverse variance weighted,8,0.95 [0.84-1.08],0.452847838138074
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",Inverse variance weighted,8,0.98 [0.72-1.35],0.916114762538819
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,Inverse variance weighted,8,1.94 [0.87-4.33],0.107269660496179
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",Inverse variance weighted,8,0.90 [0.79-1.03],0.12212234398108
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,Inverse variance weighted,8,1.17 [0.92-1.50],0.207039177966157
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,Inverse variance weighted,8,1.23 [0.88-1.71],0.225108707895807
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",Inverse variance weighted,8,1.05 [0.93-1.18],0.421550270117016
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,Inverse variance weighted,8,0.95 [0.35-2.63],0.92849624715172
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,Inverse variance weighted,8,0.93 [0.79-1.11],0.428566518956076
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,Inverse variance weighted,8,0.89 [0.66-1.20],0.440910190047806
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,Inverse variance weighted,8,0.84 [0.67-1.04],0.1091564252853
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,Inverse variance weighted,8,1.04 [0.94-1.14],0.497145434468363
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,Inverse variance weighted,8,1.00 [0.91-1.10],0.980913734329387
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,Inverse variance weighted,8,0.82 [0.30-2.23],0.69597612378614
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,Inverse variance weighted,8,0.87 [0.60-1.27],0.476790814866106
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,Inverse variance weighted,8,0.97 [0.83-1.14],0.732883697881655
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,Inverse variance weighted,8,1.01 [0.92-1.10],0.833248545046891
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,Inverse variance weighted,8,0.94 [0.74-1.20],0.642354085404099
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",Inverse variance weighted,8,1.07 [0.85-1.35],0.547224914261509
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,Inverse variance weighted,8,1.04 [0.97-1.11],0.250829488056914
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,Inverse variance weighted,8,1.06 [0.99-1.12],0.0958685240583815
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter VI Diseases of the nervous system,Falls/tendency to fall,Inverse variance weighted,8,1.01 [0.93-1.09],0.881964696225692
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter VI Diseases of the nervous system,Hemiplegia,Inverse variance weighted,8,1.13 [0.82-1.55],0.461727603588835
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",Inverse variance weighted,8,1.13 [0.96-1.34],0.147712070117792
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",Inverse variance weighted,8,1.01 [0.85-1.20],0.890055687152354
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),Inverse variance weighted,8,1.07 [0.87-1.33],0.525135354638684
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,Inverse variance weighted,8,1.10 [0.98-1.22],0.0935366000009628
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,Angina pectoris,Inverse variance weighted,8,1.01 [0.92-1.11],0.792663499488788
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,Aortic aneurysm,Inverse variance weighted,8,1.00 [0.86-1.16],0.995455786777596
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,Inverse variance weighted,8,1.13 [0.65-1.96],0.666257635095764
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,Inverse variance weighted,8,1.01 [0.65-1.57],0.957664138021333
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,Inverse variance weighted,8,1.05 [0.82-1.33],0.705514503239403
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",Inverse variance weighted,8,1.05 [0.94-1.16],0.420661116269067
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,AV-block,Inverse variance weighted,8,0.97 [0.80-1.16],0.708002697552845
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,Cardiac arrest,Inverse variance weighted,8,1.05 [0.79-1.40],0.748930136310779
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,Cardiomyopathy,Inverse variance weighted,8,0.95 [0.80-1.13],0.584438003392884
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",Inverse variance weighted,8,0.80 [0.62-1.03],0.0786199373387518
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",Inverse variance weighted,8,0.96 [0.72-1.27],0.759341145534603
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,Inverse variance weighted,8,1.04 [0.94-1.15],0.473308981257842
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,Conduction disorders,Inverse variance weighted,8,1.09 [0.96-1.24],0.197071839395525
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,Inverse variance weighted,8,1.01 [0.92-1.12],0.796993279615561
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,"Heart failure, strict",Inverse variance weighted,8,1.01 [0.92-1.10],0.864171439686815
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,Hypotension,Inverse variance weighted,8,1.21 [1.00-1.46],0.0488786501691118
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,"Hypertension, essential",Inverse variance weighted,8,1.04 [0.89-1.20],0.636270713950573
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,Hypertension,Inverse variance weighted,8,1.03 [0.89-1.19],0.713143779497592
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",Inverse variance weighted,8,0.47 [0.18-1.20],0.114204659326125
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,Inverse variance weighted,8,1.18 [0.62-2.27],0.614926367012348
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",Inverse variance weighted,8,1.03 [0.95-1.12],0.506303585010893
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,Inverse variance weighted,8,1.13 [1.02-1.25],0.0149618304438141
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,Left bundle-branch block,Inverse variance weighted,8,1.42 [1.07-1.89],0.0162602961146595
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,Inverse variance weighted,8,1.13 [0.74-1.71],0.570801226572179
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",Inverse variance weighted,8,1.02 [0.90-1.16],0.772740850343966
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,Other arrhythmias,Inverse variance weighted,8,1.04 [0.95-1.14],0.380155375653475
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,Inverse variance weighted,8,0.86 [0.63-1.19],0.373794760738847
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,Inverse variance weighted,8,1.20 [0.68-2.13],0.534240116185208
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,Inverse variance weighted,8,0.98 [0.75-1.28],0.893532317804765
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,Inverse variance weighted,8,1.10 [0.93-1.30],0.258179470876548
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,DVT of lower extremities,Inverse variance weighted,8,1.05 [0.92-1.21],0.470016329011746
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),Inverse variance weighted,8,1.00 [0.86-1.16],0.996582512646386
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,Pulmonary embolism,Inverse variance weighted,8,1.05 [0.91-1.21],0.502242946774589
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,Right bundle-branch block,Inverse variance weighted,8,0.69 [0.43-1.11],0.129792623187042
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,Inverse variance weighted,8,1.48 [0.93-2.37],0.101303616778638
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,Secondary right heart disease,Inverse variance weighted,8,0.54 [0.37-0.79],0.0015731342765774
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,Inverse variance weighted,8,1.16 [1.00-1.35],0.0456615243730684
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",Inverse variance weighted,8,1.01 [0.92-1.10],0.883470970103134
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,Oesophageal varices,Inverse variance weighted,8,0.84 [0.57-1.25],0.39494419145863
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter IX Diseases of the circulatory system,Venous thromboembolism,Inverse variance weighted,8,1.00 [0.91-1.09],0.928578514168656
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter X Diseases of the respiratory system,Interstitial lung disease,Inverse variance weighted,8,0.85 [0.69-1.05],0.130146320707655
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),Inverse variance weighted,8,1.16 [0.97-1.38],0.097901990859896
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,Inverse variance weighted,8,0.89 [0.63-1.26],0.508022166747861
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,Inverse variance weighted,8,1.12 [0.93-1.35],0.230456328872264
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter X Diseases of the respiratory system,Emphysema,Inverse variance weighted,8,0.93 [0.69-1.24],0.600040736498816
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,Inverse variance weighted,8,0.95 [0.78-1.14],0.561927985182242
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter X Diseases of the respiratory system,All influenza,Inverse variance weighted,8,1.04 [0.89-1.21],0.622876995342778
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter X Diseases of the respiratory system,Influenza and pneumonia,Inverse variance weighted,8,1.03 [0.98-1.09],0.231412782397876
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,Inverse variance weighted,8,1.03 [0.95-1.13],0.460202156272958
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,Inverse variance weighted,8,1.02 [0.93-1.12],0.649040308287401
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter X Diseases of the respiratory system,Other diseases of pleura,Inverse variance weighted,8,1.02 [0.92-1.14],0.656419090508932
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter X Diseases of the respiratory system,Pleural effusion,Inverse variance weighted,8,0.99 [0.82-1.20],0.925503608197864
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,Inverse variance weighted,8,0.93 [0.72-1.20],0.573897682011045
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter X Diseases of the respiratory system,Pulmonary oedema,Inverse variance weighted,8,0.64 [0.27-1.50],0.301142884672626
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter X Diseases of the respiratory system,Viral pneumonia,Inverse variance weighted,8,1.11 [0.88-1.40],0.365532509770222
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,Inverse variance weighted,8,1.04 [0.94-1.16],0.451583737419989
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XI Diseases of the digestive system,Alcoholic liver disease,Inverse variance weighted,8,1.07 [0.84-1.36],0.573647776974344
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XI Diseases of the digestive system,Cholelithiasis,Inverse variance weighted,8,1.06 [0.98-1.15],0.157557940089203
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XI Diseases of the digestive system,Constipation,Inverse variance weighted,8,0.99 [0.89-1.10],0.800757816848379
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XI Diseases of the digestive system,Other diseases of liver,Inverse variance weighted,8,1.04 [0.81-1.33],0.770541328324593
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,Inverse variance weighted,8,0.99 [0.89-1.11],0.900669935126148
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,Inverse variance weighted,8,1.07 [0.97-1.18],0.165587646015167
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,Inverse variance weighted,8,0.84 [0.63-1.13],0.251413553466762
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",Inverse variance weighted,8,1.11 [0.74-1.66],0.621175025142419
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XI Diseases of the digestive system,Other diseases of intestines,Inverse variance weighted,8,1.01 [0.94-1.09],0.761599411452548
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XI Diseases of the digestive system,Diseases of liver,Inverse variance weighted,8,0.97 [0.85-1.10],0.626313277403624
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XI Diseases of the digestive system,Diseases of the digestive system,Inverse variance weighted,8,0.92 [0.82-1.04],0.171848789117442
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,Inverse variance weighted,8,0.90 [0.79-1.02],0.110823659558618
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,Inverse variance weighted,8,0.93 [0.67-1.30],0.676035874588635
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,Inverse variance weighted,8,1.11 [0.97-1.28],0.136741807110789
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,Inverse variance weighted,8,0.98 [0.84-1.15],0.840066583994016
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),Inverse variance weighted,8,1.20 [1.04-1.39],0.0144550101624741
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XI Diseases of the digestive system,Other diseases of intestine,Inverse variance weighted,8,1.01 [0.81-1.27],0.903040172418704
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XI Diseases of the digestive system,Other diseases of pancreas,Inverse variance weighted,8,1.16 [0.85-1.58],0.342593687273155
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XI Diseases of the digestive system,Acute peritonitis,Inverse variance weighted,8,1.34 [0.96-1.88],0.0863947186896838
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,Inverse variance weighted,8,1.02 [0.75-1.37],0.919740876831237
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter V Mental and behavioural disorders,Any mental disorder,Inverse variance weighted,8,1.02 [0.98-1.07],0.334274712976712
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",Inverse variance weighted,8,1.03 [0.94-1.13],0.479809479635161
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,Inverse variance weighted,8,0.97 [0.83-1.13],0.666573939741526
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,Inverse variance weighted,8,0.99 [0.71-1.36],0.928970694643951
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,Inverse variance weighted,8,0.98 [0.90-1.07],0.645115233604308
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,Inverse variance weighted,8,1.03 [0.94-1.13],0.517284878919584
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",Inverse variance weighted,8,1.22 [0.99-1.49],0.0577673136968287
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,Inverse variance weighted,8,1.03 [0.98-1.07],0.240170697415386
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,Inverse variance weighted,8,1.04 [0.93-1.16],0.519723707127384
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,Inverse variance weighted,8,0.96 [0.79-1.16],0.654139295721813
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,Inverse variance weighted,8,1.08 [0.97-1.20],0.179335873202589
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,Inverse variance weighted,8,1.00 [0.94-1.06],0.977359672204427
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",Inverse variance weighted,8,0.98 [0.92-1.04],0.506767382762894
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,Inverse variance weighted,8,0.99 [0.77-1.27],0.942581547654919
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,Inverse variance weighted,8,0.99 [0.90-1.08],0.752971487901458
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,Inverse variance weighted,8,1.00 [0.91-1.10],0.967049708857752
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,Inverse variance weighted,8,0.83 [0.55-1.26],0.385236752204527
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,Inverse variance weighted,8,1.04 [0.98-1.11],0.161431214584612
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,Inverse variance weighted,8,1.03 [0.94-1.12],0.551725871710298
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,Inverse variance weighted,8,1.03 [0.89-1.20],0.664496937984669
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,Inverse variance weighted,8,1.24 [0.89-1.71],0.198855840484927
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",Inverse variance weighted,8,1.03 [0.97-1.10],0.347440243480435
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIV Diseases of the genitourinary system,Acute renal failure,Inverse variance weighted,8,1.11 [0.87-1.43],0.406504342335332
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,Inverse variance weighted,8,0.92 [0.63-1.34],0.668137287029827
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,Inverse variance weighted,8,1.06 [0.84-1.35],0.629257510994955
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,Inverse variance weighted,8,1.38 [1.02-1.86],0.038275972138158
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIV Diseases of the genitourinary system,Dialysis,Inverse variance weighted,8,1.05 [0.65-1.69],0.835845200556702
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,Inverse variance weighted,8,0.89 [0.70-1.12],0.317093080187707
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,Inverse variance weighted,8,0.90 [0.69-1.17],0.437968037709407
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,Inverse variance weighted,8,1.32 [1.07-1.63],0.0092952946806015
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,Inverse variance weighted,8,0.99 [0.76-1.30],0.962231662682264
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,Inverse variance weighted,8,1.18 [0.78-1.80],0.436012321592888
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,Inverse variance weighted,8,1.31 [0.51-3.32],0.575427237497504
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,Inverse variance weighted,8,0.96 [0.86-1.08],0.530838075326438
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,Inverse variance weighted,8,1.37 [0.98-1.89],0.0625867413748478
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",Inverse variance weighted,8,0.92 [0.66-1.28],0.629047020307875
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,Inverse variance weighted,8,0.97 [0.89-1.06],0.49091362614268
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,Inverse variance weighted,8,0.97 [0.90-1.04],0.389823038673555
HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Chapter V Mental and behavioural disorders,Smoking dependency,Inverse variance weighted,8,1.03 [0.79-1.34],0.838170383635899
